| Zacks Company Profile for CV Sciences, Inc. (CVSI : OTC) |
|
|
| |
| • Company Description |
| CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States.
Number of Employees: 49 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.06 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 1,275,550 shares |
| Shares Outstanding: 184.79 (millions) |
| Market Capitalization: $11.35 (millions) |
| Beta: 0.29 |
| 52 Week High: $0.10 |
| 52 Week Low: $0.02 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
136.15% |
136.55% |
| 12 Week |
41.15% |
38.87% |
| Year To Date |
0.00% |
0.00% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
9530 Padgett Street Suite 107
-
San Diego,CA 92126
USA |
ph: 866-290-2157
fax: 619-876-4321 |
ir@cvsciences.com |
http://www.cvsciences.com |
|
|
| |
| • General Corporate Information |
Officers
Joseph D. Dowling - Chief Executive Officer and Director
Joerg Grasser - Chief Financial Officer
Jamie Corroon - Director
Bill McCorkle - Director
Beth Altman - Director
|
|
Peer Information
CV Sciences, Inc. (GSAC)
CV Sciences, Inc. (CASI)
CV Sciences, Inc. (ALCD.)
CV Sciences, Inc. (OMNN)
CV Sciences, Inc. (CGPI.)
CV Sciences, Inc. (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 126654102
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 03/26/26
|
|
Share - Related Items
Shares Outstanding: 184.79
Most Recent Split Date: (:1)
Beta: 0.29
Market Capitalization: $11.35 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 03/26/26 |
|
|
|
| |
